NM_002880.4(RAF1):c.981A>G (p.Lys327=) AND not specified

Germline classification:: Likely benign (1 submission)
Last evaluated:: Nov 9, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001269259.1

Allele description [Variation Report for NM_002880.4(RAF1):c.981A>G (p.Lys327=)]

NM_002880.4(RAF1):c.981A>G (p.Lys327=)

Gene:

RAF1:Raf-1 proto-oncogene, serine/threonine kinase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3p25.2

Genomic location:

Preferred name:

NM_002880.4(RAF1):c.981A>G (p.Lys327=)

HGVS:

NC_000003.12:g.12600161T>C
NG_007467.1:g.69019A>G
NM_001354689.3:c.1041A>G
NM_001354690.3:c.981A>G
NM_001354691.3:c.738A>G
NM_001354692.3:c.738A>G
NM_001354693.3:c.882A>G
NM_001354694.3:c.798A>G
NM_001354695.3:c.639A>G
NM_002880.4:c.981A>GMANE SELECT
NP_001341618.1:p.Lys347=
NP_001341619.1:p.Lys327=
NP_001341620.1:p.Lys246=
NP_001341621.1:p.Lys246=
NP_001341622.1:p.Lys294=
NP_001341623.1:p.Lys266=
NP_001341624.1:p.Lys213=
NP_002871.1:p.Lys327=
LRG_413t1:c.981A>G
LRG_413t2:c.1041A>G
LRG_413:g.69019A>G
LRG_413p2:p.Lys347=
NC_000003.11:g.12641660T>C
NM_002880.3:c.981A>G
NR_148940.3:n.1312A>G
NR_148941.3:n.1312A>G
NR_148942.3:n.1312A>G

Links:

dbSNP: rs2058814646

NCBI 1000 Genomes Browser:

rs2058814646

Molecular consequence:

NR_148940.3:n.1312A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148941.3:n.1312A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148942.3:n.1312A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NM_001354689.3:c.1041A>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001354690.3:c.981A>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001354691.3:c.738A>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001354692.3:c.738A>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001354693.3:c.882A>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001354694.3:c.798A>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001354695.3:c.639A>G - synonymous variant - [Sequence Ontology: SO:0001819]
NM_002880.4:c.981A>G - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Homo sapiens hyaluronoglucosaminidase 4, mRNA (cDNA clone MGC:132448 IMAGE:81437...
Homo sapiens hyaluronoglucosaminidase 4, mRNA (cDNA clone MGC:132448 IMAGE:8143791), complete cds
gi|85396868|gb|BC104788.1|

Nucleotide
Paracoccus sp. XF-30 isolate:soli
Paracoccus sp. XF-30 isolate:soli
Paracoccus sp. XF-30 isolate:soli Genome sequencing

BioProject
Glucocorticoids-triggered CXCR4 signaling activates the PLC signalosome and prom...
Glucocorticoids-triggered CXCR4 signaling activates the PLC signalosome and promotes tumor resistance in B cell acute lymphoblastic leukemia
Glucocorticoids-triggered CXCR4 signaling activates the PLC signalosome and promotes tumor resistance in B cell acute lymphoblastic leukemia

BioProject
RecName: Full=Y-box-binding protein 2; AltName: Full=Contrin; AltName: Full=DNA-...
RecName: Full=Y-box-binding protein 2; AltName: Full=Contrin; AltName: Full=DNA-binding protein C; Short=Dbpc; AltName: Full=Germ cell-specific Y-box-binding protein; AltName: Full=MSY2 homolog
gi|116242847|sp|Q9Y2T7.2|YBOX2_HUMA

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001448587	Women's Health and Genetics/Laboratory Corporation of America, LabCorp	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015)	Likely benign (Nov 9, 2020)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001448587

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)

Likely benign
(Nov 9, 2020)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001448587.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Apr 23, 2022

ClinVar

Relating variation to medicine